Closed
SectorHealthcare
55.69 1.96
24h
Min
54.11
Max
55.97
Income | -11M -77M |
---|---|
Sales | -11M 11M |
EPS | -0.95 |
Profit margin | -667.602 |
Employees | 218 |
EBITDA | -21M -85M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +17.33% upside |
Next Earnings | 31 Oct 2025 |
---|
Market Cap | 1.5B 4.2B |
---|---|
Previous open | 53.73 |
Previous close | 55.69 |
By Acuity
50%
50%
149 / 371 Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 64.13 USD 17.33%
High 88 USD
Low 53 USD
Based on 17 Wall Street analysts offering 12 month price targets forKymera Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$